These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34871095)
1. Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas. Walter K; Kokesch-Himmelreich J; Treu A; Waldow F; Hillemann D; Jakobs N; Lemm AK; Schwudke D; Römpp A; Hölscher C Antimicrob Agents Chemother; 2022 Jun; 66(6):e0158821. PubMed ID: 34871095 [TBL] [Abstract][Full Text] [Related]
2. Do Anti-tuberculosis Drugs Reach Their Target?─High-Resolution Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Provides Information on Drug Penetration into Necrotic Granulomas. Kokesch-Himmelreich J; Treu A; Race AM; Walter K; Hölscher C; Römpp A Anal Chem; 2022 Apr; 94(14):5483-5492. PubMed ID: 35344339 [TBL] [Abstract][Full Text] [Related]
3. Integrating High-Resolution MALDI Imaging into the Development Pipeline of Anti-Tuberculosis Drugs. Treu A; Kokesch-Himmelreich J; Walter K; Hölscher C; Römpp A J Am Soc Mass Spectrom; 2020 Nov; 31(11):2277-2286. PubMed ID: 32965115 [TBL] [Abstract][Full Text] [Related]
4. Visualization of Mycobacterial Biomarkers and Tuberculosis Drugs in Infected Tissue by MALDI-MS Imaging. Blanc L; Lenaerts A; Dartois V; Prideaux B Anal Chem; 2018 May; 90(10):6275-6282. PubMed ID: 29668262 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis. Driver ER; Ryan GJ; Hoff DR; Irwin SM; Basaraba RJ; Kramnik I; Lenaerts AJ Antimicrob Agents Chemother; 2012 Jun; 56(6):3181-95. PubMed ID: 22470120 [TBL] [Abstract][Full Text] [Related]
6. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas. Irwin SM; Gruppo V; Brooks E; Gilliland J; Scherman M; Reichlen MJ; Leistikow R; Kramnik I; Nuermberger EL; Voskuil MI; Lenaerts AJ Antimicrob Agents Chemother; 2014 Jul; 58(7):4026-34. PubMed ID: 24798275 [TBL] [Abstract][Full Text] [Related]
7. The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology. Heitmann L; Abad Dar M; Schreiber T; Erdmann H; Behrends J; Mckenzie AN; Brombacher F; Ehlers S; Hölscher C J Pathol; 2014 Nov; 234(3):338-50. PubMed ID: 24979482 [TBL] [Abstract][Full Text] [Related]
8. The association between sterilizing activity and drug distribution into tuberculosis lesions. Prideaux B; Via LE; Zimmerman MD; Eum S; Sarathy J; O'Brien P; Chen C; Kaya F; Weiner DM; Chen PY; Song T; Lee M; Shim TS; Cho JS; Kim W; Cho SN; Olivier KN; Barry CE; Dartois V Nat Med; 2015 Oct; 21(10):1223-7. PubMed ID: 26343800 [TBL] [Abstract][Full Text] [Related]
9. Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for Arrey F; Löwe D; Kuhlmann S; Kaiser P; Moura-Alves P; Krishnamoorthy G; Lozza L; Maertzdorf J; Skrahina T; Skrahina A; Gengenbacher M; Nouailles G; Kaufmann SHE Front Immunol; 2019; 10():89. PubMed ID: 30766535 [TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs. Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149 [TBL] [Abstract][Full Text] [Related]
11. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models. Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020 [TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models. Ahmad Z; Fraig MM; Pinn ML; Tyagi S; Nuermberger EL; Grosset JH; Karakousis PC J Antimicrob Chemother; 2011 Jul; 66(7):1560-6. PubMed ID: 21602551 [TBL] [Abstract][Full Text] [Related]
14. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis. Montgomery SA; Young EF; Durham PG; Zulauf KE; Rank L; Miller BK; Hayden JD; Lin FC; Welch JT; Hickey AJ; Braunstein M PLoS One; 2018; 13(9):e0204495. PubMed ID: 30261007 [TBL] [Abstract][Full Text] [Related]
16. Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. Harper J; Skerry C; Davis SL; Tasneen R; Weir M; Kramnik I; Bishai WR; Pomper MG; Nuermberger EL; Jain SK J Infect Dis; 2012 Feb; 205(4):595-602. PubMed ID: 22198962 [TBL] [Abstract][Full Text] [Related]
18. Immunopathology of Pulmonary Kolloli A; Kumar R; Venketaraman V; Subbian S Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338937 [TBL] [Abstract][Full Text] [Related]
19. Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies. Kramnik I; Beamer G Semin Immunopathol; 2016 Mar; 38(2):221-37. PubMed ID: 26542392 [TBL] [Abstract][Full Text] [Related]
20. High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types. Blanc L; Daudelin IB; Podell BK; Chen PY; Zimmerman M; Martinot AJ; Savic RM; Prideaux B; Dartois V Elife; 2018 Nov; 7():. PubMed ID: 30427309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]